Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 99 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 8,650 followers.

@ariesjill It' a heterogenous group with some subtypes https://t.co/YeNqqnGKDm BRACA1 is in 15% of the cancers tested.

Reply Repost Favourite

RT @JournalofExper1: New Review!💣 𝐇𝐞𝐭𝐞𝐫𝐨𝐠𝐞𝐧𝐞𝐢𝐭𝐲 𝐨𝐟 #𝐭𝐫𝐢𝐩𝐥𝐞𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞𝐛𝐫𝐞𝐚𝐬𝐭𝐜𝐚𝐧𝐜𝐞𝐫: 𝐂𝐮𝐫𝐫𝐞𝐧𝐭 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐬𝐮𝐛𝐭𝐲𝐩𝐢𝐧𝐠 𝐚𝐧𝐝 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐢𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬…

Reply Repost Favourite

New Review!💣 𝐇𝐞𝐭𝐞𝐫𝐨𝐠𝐞𝐧𝐞𝐢𝐭𝐲 𝐨𝐟 #𝐭𝐫𝐢𝐩𝐥𝐞𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞𝐛𝐫𝐞𝐚𝐬𝐭𝐜𝐚𝐧𝐜𝐞𝐫: 𝐂𝐮𝐫𝐫𝐞𝐧𝐭 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐬𝐮𝐛𝐭𝐲𝐩𝐢𝐧𝐠 𝐚𝐧𝐝 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐢𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 👇 https://t.co/OK9h2n5Aog #MolecularSubtyping @IREISGufficiale https://t.co/NU1wNNo5tg

Reply Repost Favourite

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications #bcsm #breastcancer https://t.co/XLuoGG20gI

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.